Posted in | News | Medical Optics | Microscopy

Maven Semantic Updates Fluorescence Microscopy Research Database

Maven Semantic has released updates on its Fluorescence Microscopy research database. Users can search more than 7,000 research organizations and over 80,000 individuals in the database.

The new database comprises government labs, hospitals, CROs, biotech companies, pharmaceutical companies and other firms in the field of fluorescence microscopy research. The database can be accessed by KOL, competitor intelligence, business development, medical affairs, marketing and other associated departments of the life science industry. It tags 80,000 people operating in the fluorescence microscopy field.

The leading 10 countries in the fluorescence microscopy research are the USA, Japan, Germany, United Kingdom, France, China, Canada, Italy, the Netherlands and Australia.

The database includes a number of sample companies, namely Novartis Pharma, Molecular Probes, Japan Science and Technology, Inex Pharmaceuticals, Hitachi, GlycoMimetics, Genentech, Envirogen, Eli Lilly and Company, CVPath Institute, CLONTECH Laboratories, Cellomics, Beiersdorf, Bayer, BASF, AntiCancer, Amnis and Amgen. It covers various organizations such as Massachusetts General Hospital, National University of Singapore, Kyushu University, Cornell University, Chinese Academy of Sciences, California Institute of Technology and Boston University School of Medicine.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.